These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29180644)

  • 1. Genome editing for the reproduction and remedy of human diseases in mice.
    Hara S; Takada S
    J Hum Genet; 2018 Feb; 63(2):107-113. PubMed ID: 29180644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 therapeutics for liver diseases.
    Aravalli RN; Steer CJ
    J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.
    Uno N; Abe S; Oshimura M; Kazuki Y
    J Hum Genet; 2018 Feb; 63(2):145-156. PubMed ID: 29180645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
    Dever DP; Porteus MH
    Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Therapeutic Genome Editing in China.
    Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.
    Babačić H; Mehta A; Merkel O; Schoser B
    PLoS One; 2019; 14(2):e0212198. PubMed ID: 30794581
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ma X; Wong AS; Tam HY; Tsui SY; Chung DL; Feng B
    Zool Res; 2018 Mar; 39(2):58-71. PubMed ID: 29515088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of genome editing technologies in rats for human disease models.
    Yoshimi K; Mashimo T
    J Hum Genet; 2018 Feb; 63(2):115-123. PubMed ID: 29158599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-engineered genome editing for the next generation neurological disease modeling.
    Feng W; Liu HK; Kawauchi D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():459-467. PubMed ID: 28536069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 Genome Editing in Embryonic Stem Cells.
    Andrey G; Spielmann M
    Methods Mol Biol; 2017; 1468():221-34. PubMed ID: 27662879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-Assisted Genome Editing in Murine Embryonic Stem Cells.
    Gruzdev A; Scott GJ; Hagler TB; Ray MK
    Methods Mol Biol; 2019; 1960():1-21. PubMed ID: 30798517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide editing without DNA cleavage using CRISPR/Cas9-deaminase in the sea urchin embryo.
    Shevidi S; Uchida A; Schudrowitz N; Wessel GM; Yajima M
    Dev Dyn; 2017 Dec; 246(12):1036-1046. PubMed ID: 28857338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae.
    Katayama T; Tanaka Y; Okabe T; Nakamura H; Fujii W; Kitamoto K; Maruyama J
    Biotechnol Lett; 2016 Apr; 38(4):637-42. PubMed ID: 26687199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prime Time for Genome Editing?
    Urnov FD
    N Engl J Med; 2020 Jan; 382(5):481-484. PubMed ID: 31995698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.